Skip to main content
SpringerLink
Log in

Ocular Adnexal Lymphoproliferative Disease

  • Chapter
Oculoplastics and Orbit

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 1779 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abramson DH, Rollins I, Coleman M (2005) Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics. Am J Ophthalmol 140:729–730

    Article  PubMed  CAS  Google Scholar 

  2. Adami J, Frisch M, Yuen J, et al (1995) Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 310:1491–1495

    Article  PubMed  CAS  Google Scholar 

  3. Agostinelli C, Piccaluga P, Went P (2008) Peripheral T cell lymphoma, not otherwise specified: the stuf of genes, dreams and therapies. J Clin Pathol 61:1160–1167

    Article  PubMed  CAS  Google Scholar 

  4. Aifantis I, Raetz E, Buonamici S (2008) Molecular patho-genesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8:380–390

    Article  PubMed  CAS  Google Scholar 

  5. Allen-Auerbach M, Quon A, Weber WA, et al (2004) Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 6:411–416

    Article  PubMed  Google Scholar 

  6. Allen-Auerbach M, de Vos S, Czernin J (2008) The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin N Am 46:199–121

    Article  PubMed  Google Scholar 

  7. Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party. Guidelines for the diagnosis and management of lymphoma. The Cancer Council Australia and Australian Cancer Network, Sydney 2005

    Google Scholar 

  8. Auw-Haedrich C, Coupland SE, Kapp A, et al (2001) Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classif cation. Br J Ophthalmol 85:63–69

    Article  PubMed  CAS  Google Scholar 

  9. Bahler D, Szankasi P, Kulkarni S (2009) Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa. Mod Pathol. doi:10.1038/modpathol. 2009.42

    Google Scholar 

  10. Ben Simon GJ, Cheung N, McKelvie P, et al (2006) Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa associated lymphoid tissue of the orbit. Ophthalmology 113:1209–1213

    Article  PubMed  Google Scholar 

  11. Bende R, Smit L, van Noesel C (2007) Molecular pathways in follicular lymphoma. Leukemia 2:18–29

    Google Scholar 

  12. Benetatos L, Alymara V, Asproudis I, et al (2006) Rituximab as first line treatment for MALT lymphoma of extraocular muscles. Ann Hematol 85:625–626

    Article  PubMed  Google Scholar 

  13. Blasi MA, Gherlinzoni F, Calvisi G, et al (2001) Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology 108:559–562

    Article  PubMed  CAS  Google Scholar 

  14. Byrne GI, Ojcius DM (2004) Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2:802–808

    Article  PubMed  CAS  Google Scholar 

  15. Cahill M, Barnes C, Moriarty P, et al (1999) Ocular adnexal lymphoma—a comparison of MALT lymphoma with other histological types. Br J Ophthalmol 83:742–747

    Article  PubMed  CAS  Google Scholar 

  16. Campbell L (2005) Cytogenetics of lymphomas. Pathology 37:493–507

    Article  PubMed  CAS  Google Scholar 

  17. Carbonne P P, Kaplan HS, Mushoff HS, et al (1971) Report of the nomenclature committee on Hodgkin's disease staging. Cancer Res 311:860–861

    Google Scholar 

  18. Chan-Kai B, Yen M (2005) Combined PET/CT imaging of orbital lymphoma. Am J Ophthalmol 140:531–533

    Article  PubMed  Google Scholar 

  19. Cheson BD (2003) Radioimmunotherapy of non-Hodgkin's lymphomas. Blood 101:391–398

    Article  PubMed  CAS  Google Scholar 

  20. Cheson BD, Leonard JP (2008) Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N Engl J Med 359:613–626

    Article  PubMed  CAS  Google Scholar 

  21. Ci W, Polo J, Melnick A (2008) B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr Opin Hematol 15:381–390

    Article  PubMed  CAS  Google Scholar 

  22. Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94:2015–2023

    Article  PubMed  Google Scholar 

  23. Cleary ML, Sklar J (1984) Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet ii 8401:489–493

    Article  Google Scholar 

  24. Coffee R, Lazarchick J, Chévez-Barios P, et al (2005) Rapid diagnosis of orbital mantle cell lymphoma utilizing fluo-rescent in situ hybridization technology. Am J Ophthalmol 140:554–555

    Article  PubMed  Google Scholar 

  25. Coiffier B, Lepage E, Briere J, et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235–242

    Article  PubMed  CAS  Google Scholar 

  26. Coupland SE, Krause L, Delecluse HJ, et al (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 105:1430–1441

    Article  PubMed  CAS  Google Scholar 

  27. Coupland SE, Foss H-D, Assaf C, et al (1999) T-cell and T/ natural killer-cell lymphomas involving ocular and ocular adnexal tissues. Ophthalmology 106:2109–2120

    Article  PubMed  CAS  Google Scholar 

  28. Coupland SE, Hellmich M, Auw-Haedrich C, et al (2004) Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases Graefe's. Arch Clin Exp Ophthalmol 242:130–145

    Article  Google Scholar 

  29. Czuczman MS, Weaver R, Alkuzweny B, et al (2004) Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol 22:4711–6 [Erratum (2005) J Clin Oncol 23 248]

    Article  PubMed  CAS  Google Scholar 

  30. Czuczman MS, Koryzna A, Mohr A, et al (2005) Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol 23:694–704

    Article  PubMed  CAS  Google Scholar 

  31. Davies AJ (2007) Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I131 tositumomab. Oncogene 26:3614–3628

    Article  PubMed  CAS  Google Scholar 

  32. De Paepe P, de Wolf-Peeters C (2007) Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities. Leukemia 21:37–43

    Article  PubMed  CAS  Google Scholar 

  33. Decaudin D, Dendale R, Lumbroso-Le R (2008) Treatment of mucosa-associated lymphoid tissue-type ocular adnexal lymphoma. Anticancer Drugs 19:673–680

    Article  PubMed  CAS  Google Scholar 

  34. Decaudin D, Dolcetti R, deCremoux P, et al (2008) Variable association between Chlamydia psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variation? Anticancer Drugs 19:761–765

    Article  PubMed  CAS  Google Scholar 

  35. Demirci H, Shields CL, Karatza EC, et al (2008) Orbital lymphoproliferative tumors analysis of clinical features and systemic involvement in 160 cases. Ophthalmology 115:1626–1631

    Article  PubMed  Google Scholar 

  36. Devesa SS, Fears T (1992) Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 52(19 Suppl):5432s–54340s

    PubMed  CAS  Google Scholar 

  37. Ellis JH, Banks PM, Campbell RJ, et al (1985) Lymphoid tumors of the ocular adnexa. Clinical correlation with the working formulation classification and immunoperoxidase staining of paraffn sections. Ophthalmol 92:1311–1324

    CAS  Google Scholar 

  38. Esmaeli B, Murray JL, Ahmadi MA, et al (2002) Immuno-therapy for low-grade non-Hodgkin secondary lymphoma of the orbit. Arch Ophthalmol 120:1225–1227

    Article  PubMed  Google Scholar 

  39. Esmaeli B, McLaughlin P, Pro B, et al (2009) Prospective trial of targeted radioimmunotherapy with Y-90 ibritu-momab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol 20:709–714

    Article  PubMed  CAS  Google Scholar 

  40. Evens AM, Winter JN, Hou N, et al (2008) A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. Br J Haematol 140:385–393

    Article  PubMed  CAS  Google Scholar 

  41. Ferreri AJ, Guidoboni M, De Conciliis C, et al (2004) Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 96:586–594

    Article  PubMed  Google Scholar 

  42. Ferreri AJ, Ponzoni M, Martinelli G, et al (2005) Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa. Haematologica 90:1578–1579

    PubMed  CAS  Google Scholar 

  43. Ferreri AJ, Viale E, Guidoboni M, et al (2006) Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 17:769–772

    Article  PubMed  CAS  Google Scholar 

  44. Ferreri AJ, Dolcetti R, Du M-Q, et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19:835–846

    Article  PubMed  CAS  Google Scholar 

  45. Ferry JA, Fung C Y, Zukerberg L, et al (2007) Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 31:170–184

    Article  PubMed  Google Scholar 

  46. Filipovich AH, Mathur A, Karmat D, et al (1992) Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 52(19 Suppl):5465s–5467s

    PubMed  CAS  Google Scholar 

  47. Fisher RI, Gaynor ER, Dahlberg S, et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002–1006

    Article  PubMed  CAS  Google Scholar 

  48. Fisher S, Fisher R (2004) The epidemiology of non-Hodgkin's lymphoma. Oncogene 23:6524–6534

    Article  PubMed  CAS  Google Scholar 

  49. Foran JM, Rohatiner AZ, Cunningham D, et al (2000) European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol 18:317–324 [Erratum (2000) J Clin Oncol 18:2006]

    PubMed  CAS  Google Scholar 

  50. Freeman C, Berg J W, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252–260

    Article  PubMed  CAS  Google Scholar 

  51. Freidberg J, Fisher R (2008) Diffuse large B-cell lymphoma. Hematol Oncol Clin N Am 22:941–952.

    Article  Google Scholar 

  52. Fueger B, Yeom K, Czernin J, et al (2009) Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma. Mol Imaging Biol. (Epub 20 Mar 2009)

    Google Scholar 

  53. Fung CY, Tarbell NJ, Lacarelli MJ, et al (2003) Ocular adn-exal lymphoma: clinical behaviour of distinct World Health Organization classification subtypes. Int J Radiat Oncol Biol Phys 57:1382–1391

    Article  PubMed  Google Scholar 

  54. Garner A, Rai AH, Wright JE (1983) Lymphoproliferative disorders of the orbit: an immunological approach to diagnosis and pathogenesis. Br J Ophthalmol 67:561–569

    Article  PubMed  CAS  Google Scholar 

  55. Gausas RE, Gonnering RS, Lemke B, et al (1999) Identification of human orbital lymphatics. Ophthal Plast Reconstr Surg 15:252–259

    Article  PubMed  CAS  Google Scholar 

  56. Gausas RE, Daly T, Fogt F (2007) D2-40 expression demonstrates lymphatic vessel characteristics in the dural portion of the optic nerve sheath. Ophthal Plast Reconstr Surg 23:32–36

    Article  PubMed  Google Scholar 

  57. Gayed I, Eskandari F, McLaughlin P, et al (2007) Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy ophthalmic. Surg Lasers Imaging 38:319–325

    Google Scholar 

  58. Goedert JJ (2000). The epidemiology of acquired immu-nodef ciency syndrome malignancies. Semin Oncol 27:390–401

    PubMed  CAS  Google Scholar 

  59. Grünberger B, Hauf W, Lukas J, et al (2006) “Blind” antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann Oncol 17:484–487

    Article  PubMed  Google Scholar 

  60. Habermann TM, Weller EA, Morrison VA, et al (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121–3127

    Article  PubMed  CAS  Google Scholar 

  61. Harris NL (2001) Mature B-cell neoplasms: introduction. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissue. IARC Press, Lyon, pp 121–126

    Google Scholar 

  62. Harris NL, Isaacson PG (1999) What are the criteria for distinguishing MALT from non-MALT lymphoma at extran-odal sites? Am J Clin Pathol 111(Suppl 1): S126–S1332

    PubMed  CAS  Google Scholar 

  63. Henderson JW (1994) Hemotopoietic tumors. In: Henderson JW (ed) Orbital tumors, 3rd ed. Raven, New York, pp 279–307

    Google Scholar 

  64. Hiddemann W, Kneba M, Dreyling M, et al (2005) Frontline therapy with rituximab added to the combination of cylophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 106:3725–3732

    Article  PubMed  CAS  Google Scholar 

  65. Hu S, Federman D, Ma F, et al (2005) Skin cancer and non-Hodgkin's lymphoma: examining the link. Dermatol Surg 31:76–82

    Article  PubMed  CAS  Google Scholar 

  66. Husain A, Roberts D, Pro B, et al (2007) Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer 110:809–815

    Article  PubMed  Google Scholar 

  67. Hutchings M, Specht L (2008) PET/CT in the management of haematological malignancies. J Haematol 80:369–380

    Google Scholar 

  68. Isaacson PG (1999) Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 36:139–147

    PubMed  CAS  Google Scholar 

  69. Isaacson PG (2000) The current status of lymphoma clas-sification. Br J Haematol 109:258–266

    Article  PubMed  CAS  Google Scholar 

  70. Isaacson PG, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue. Cancer 52:1410–1416

    Article  PubMed  CAS  Google Scholar 

  71. Isaacson PG, Wright DH (1984) Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53:2515–2524

    Article  PubMed  CAS  Google Scholar 

  72. Isaacson PG, Muler-Hermelink HK, Piris MA, et al (2001) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffie ES, Harris NL, Stein H, Vardiman JW (eds) Pathology and genetics of tumors of haematopoietic and lymphoid tissue. IARC Press, Lyon, pp 157–160

    Google Scholar 

  73. Jafie ES, Harris NL, Diebold J, et al (1999) World health organisation classification of neoplastic disease of the hematopoietic and lymphoid tissues. Am J Clin Pathol 111(Suppl):S8–S12

    Google Scholar 

  74. Jakobiec FA (1982) Orbital inflammations and lymphoid tumours. Trans New Orleans Acad Ophthalmol 30:52–85

    PubMed  CAS  Google Scholar 

  75. Jakobiec FA (1983) Ocular inflammatory disease: the lymphocyte redivivus. Am J Ophthalmol 96:384–391

    PubMed  CAS  Google Scholar 

  76. Jakobiec FA, Knowles DM (1989) An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc 87:420–442

    PubMed  CAS  Google Scholar 

  77. Jakobiec FA, McLean I, Font RL (1979) Clinicopathologic characteristics of orbital lymphoid hyperplasia. Ophthalmology 86:948–966

    PubMed  CAS  Google Scholar 

  78. Jakobiec FA, Iwamoto T, Knowles DM (1982) Ocular adnexal lymphoid tumors. Correlative ultrastructural and immunologic marker studies. Arch Ophthalmol 100:84–98

    Article  CAS  Google Scholar 

  79. Jakobiec FA, Iwamoto T, Patell M, et al (1986) Ocular adn-exal monoclonal lymphoid tumors with a favourable prognosis. Ophthalmology 93:1547–1557

    PubMed  CAS  Google Scholar 

  80. Jakobiec FA, Neri A, Knowles DM (1987) Genotypic monoclonality in immunophenotypically polyclonal orbital lymphoid tumors. A model of tumor progression in the lymphoid system. Ophthalmology 94:980–994

    PubMed  CAS  Google Scholar 

  81. Jardin F, Ruminy P, Bastard C, et al (2007) The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis. Pathol Biologie 55:73–83

    Article  CAS  Google Scholar 

  82. Jares P, Colomer D, Campo E (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7:750–762

    Article  PubMed  CAS  Google Scholar 

  83. Jemal A, Siegel R, Ward E, et al (2008) Cancer statistics. CA Cancer J Clin 58:71–96. (Epub 20 Feb 2008)

    Article  PubMed  Google Scholar 

  84. Jenkins C, Rose GE, Bunce C, et al (2000) Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 84:907–913

    Article  PubMed  CAS  Google Scholar 

  85. Jenkins C, Rose GE, Bunce C, et al (2003) Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye 17:809–820

    Article  PubMed  CAS  Google Scholar 

  86. Jensen A, Olesen A, Dethlefsen C, et al (2008) Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers—a population based study from Denmark. J Invest Dermatol 128:926–931

    Article  PubMed  CAS  Google Scholar 

  87. Jost PJ, Ruland J (2007) Aberrant NFkappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 109:2700–2707

    PubMed  CAS  Google Scholar 

  88. Juweid M, Cheson B (2006) Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354:496–507

    Article  PubMed  CAS  Google Scholar 

  89. Kadin M (2003) Genetic and molecular genetic studies in the diagnosis of T-cell malignancies. Hum Pathol 34:322–329

    Article  PubMed  CAS  Google Scholar 

  90. Khouri IF, Romaguera J, Kantarjian H, et al (1998) Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 16:3803–3809

    PubMed  CAS  Google Scholar 

  91. Kinlen L (1992) Immunosuppressive therapy and acquired immunological disorders. Cancer Res 52(19 Suppl): 5474s–5476s

    PubMed  CAS  Google Scholar 

  92. Knop E, Knop N (2001) Lacrimal drainage—associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci 42:566–574

    PubMed  CAS  Google Scholar 

  93. Knop E, Knop N 2005 The role of eye-associated lymphoid tissue in corneal immune protection. J Anat 206:271–285

    Article  PubMed  Google Scholar 

  94. Knowles DM, Jakobiec FA (1980) Orbital lymphoid neoplasms: a clinicopathologic study of 60 patients. Cancer 46:576–589

    Article  PubMed  Google Scholar 

  95. Knowles DM, Jakobiec FA (1982) Ocular adnexal lymphoid neoplasms: clinical, histopathologic, electron microscopic, and immunologic characteristics. Hum Pathol 13:148–162

    Article  PubMed  Google Scholar 

  96. Knowles DM, Jakobiec FA, Halper JP (1979) Immunologic characterization of ocular adnexal lymphoid neoplasms. Am J Ophthalmol 87:603–619

    PubMed  Google Scholar 

  97. Knowles DM, Halper JP, Jakobiec FA (1982) The immu-nologic characterization of 40 extranodal lymphoid infil-trates: in distinguishing between benign pseudolymphoma and malignant lymphoma. Cancer 49:2321–2335

    Article  PubMed  Google Scholar 

  98. Knowles DM, Jakobiec FA, McNally L (1990) Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 21:959–973

    Article  PubMed  CAS  Google Scholar 

  99. Küppers R, Klein U, Hansmann M-L, et al (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341(20):1520–1529

    Article  PubMed  Google Scholar 

  100. Lenz G, Dreyling M, Hoster E, et al (2005) Immuno-chemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 23:1984–1992

    Article  PubMed  CAS  Google Scholar 

  101. Li BZ, Lu HF, Zhou XY, et al (2008) Frequency of genetic aberrations of mucosa-associated lymphoid tissue lymphoma of different sites. Zhonghua Bing Li Xue Za Zhi 37:604–608

    PubMed  CAS  Google Scholar 

  102. Looi A, Gascoyne RD, Chaanabhai M, et al (2005) Mantle cell lymphoma in the ocular adnexal region. Ophthalmology 112:114–119

    Article  PubMed  Google Scholar 

  103. Lucas RS, Mortimore R, Sullivan TJ, et al (2003) Interferon treatment of childhood conjunctival lymphoma. Br J Ophthalmol 87:1191

    Article  PubMed  CAS  Google Scholar 

  104. Mannami T, Yoshino T, Oshima K, et al (2001) Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 14:641–649

    Article  PubMed  CAS  Google Scholar 

  105. Marcus R, Imrie K, Solal-Celigny P, et al (2008) A phase III study of rituximab plus CVP versus CVP alone in patients with previously untreated advanced follicular lymphoma: updated results with 53 months' median follow-up and analysis of outcomes according to baseline prognostic factors. J Clin Oncol 26(28):4579–86.

    Article  PubMed  CAS  Google Scholar 

  106. Margo CE, Mulla ZD (1998) Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology 105:185–190

    CAS  Google Scholar 

  107. Matthews JM, Moreno LI, Dennis J, et al (2008) Ocular adnexal lymphoma: no evidence for bacterial DNA associated with lymphoma pathogenesis. Br J Haematol. (Epub ahead of print 19 May 2008)

    Google Scholar 

  108. Medeiros LJ, Harris NL (1989) Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophe-notypic study of 99 cases. Am J Surg Pathol 13:459–471

    Article  PubMed  CAS  Google Scholar 

  109. Medeiros LJ, Harris NL (1990) Immunohistologic analysis of small lymphocytic infiltrates of the orbit and conjunctiva. Hum Pathol 21:1126–1131

    Article  PubMed  CAS  Google Scholar 

  110. Medeiros LJ, Harmon DC, Linggood RM, et al (1989) Immunohistologic features predict clinical behaviour of orbital and conjunctival lymphoid inf ltrates. Blood 74:2121–2129

    PubMed  CAS  Google Scholar 

  111. McLaughlin P, Grillo-Lopez AJ, Link BK, et al (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy of relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 16:2825–2833

    PubMed  CAS  Google Scholar 

  112. Miyairi I, Byrne GI (2006) Chlamydia and programmed cell death. Curr Opin Microbiol 9:102–108

    Article  PubMed  CAS  Google Scholar 

  113. McKelvie PA, McNab AA, Francis IC, et al (2001) Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol 29:387–393

    Article  CAS  Google Scholar 

  114. Morgan G (1975) Lymphocytic tumours of the orbit. Mod Probl Ophthalmol 14:355–360

    PubMed  CAS  Google Scholar 

  115. Morgan G, Harry J (1978) Lymphocytic tumours of indeterminate nature: a 5-year follow-up of 98 conjunctival and orbital lesions. Br J Ophthalmol 62:381–383

    Article  PubMed  CAS  Google Scholar 

  116. Moslehi R, Devesa SS, Schairer C, et al (2006) Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J Natl Cancer Inst 98:936–939

    Article  PubMed  Google Scholar 

  117. Nakata M, Matsuno Y, Katsumata N, et al (1999) Histology according to the revised European-American lymphoma classif cation signif cantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymphoma 32:533–543

    PubMed  CAS  Google Scholar 

  118. Nguyen DT, Amess JA, Doughty H, et al (1999) IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphop-roliferative disorders: evaluation of response on 48 patients. Eur J Haematol 62:76–82

    Article  PubMed  CAS  Google Scholar 

  119. Nuckel H, Meller D, Steuhl K P, et al (2004) Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 73:258–262

    Article  PubMed  Google Scholar 

  120. Nutting CM, Shah-Desai S, Rose GE, et al (2006) Thyroid orbitopathy possibly predisposes to late-onset of periocu-lar lymphoma. Eye 20:645–648

    Article  PubMed  CAS  Google Scholar 

  121. Otte A, van de Wiele C, Dierckx RA (2009) Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step. Nucl Med Commun 30:5–15

    Article  PubMed  CAS  Google Scholar 

  122. Pals ST, De Gorter DJ Spaargaren M (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110:3102–3111

    Article  PubMed  CAS  Google Scholar 

  123. Perry C, Herishanu Y, Metzer U, et al (2007) Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol 79:205–209

    Article  PubMed  Google Scholar 

  124. Pfreundschuh M, Trumper L, Osterborg A, et al (2006) CHOP-like chemotherapy plus rituximab versus CHOPlike chemotherapy alone in young patients with good-prognosis dif use large-B-cell lymphoma: a randomised controlled trial by the Mab-Thera International Trial (MInT) Group. Lancet Oncol 7:379–391

    Article  PubMed  CAS  Google Scholar 

  125. Pfreundschuh M, Schubert J, Ziepert M, et al (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20 B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol 9:105–116

    Article  PubMed  CAS  Google Scholar 

  126. Polito E, Galieni P, Leccisotti A (1996) Clinical and radiological presentation of 95 orbital lymphoid tumors. Graefes Arch Clin Exp Ophthalmol 234:504–509

    Article  PubMed  CAS  Google Scholar 

  127. Rasmussen P, Sjo LD, Prause JU (2009) Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol. (Epub ahead of print 7 May 2009)

    Google Scholar 

  128. Roe R, Finger PT, Kurli M, et al (2006) Whole-body positron emission tomography/computed tomography imaging and staging of orbital lymphoma. Ophthalmology 113:1854–1858

    Article  PubMed  Google Scholar 

  129. Romagosa Y, Hu S, Kirsner R (2008) Chronic diseases and non-Melanoma skin cancer: is there an association? J Invest Dermatol 128:768

    Article  PubMed  CAS  Google Scholar 

  130. Roos E (1991) Adhesion molecules in lymphoma metastasis. Cancer Metastasis Rev 10:33–48

    Article  PubMed  CAS  Google Scholar 

  131. Schotterfield D, Beebe-Dimmer J (2006) Chronic inflam-mation: a common and important factor in the pathogen-esis of neoplasia. CA Cancer J Clin 56:69–83

    Article  Google Scholar 

  132. Sharkey RM, Press OW, Goldenberg DM (2009) A re-examination of radioimmunotherapy in the treatment of non-Hodgkins lymphoma: prospects for dual-targeted antibody/radioantibody therapy. Blood 113:3891–3895

    Article  PubMed  CAS  Google Scholar 

  133. Shen D, Yuen HKL (2006) Detection of chlamydia pneumonia in a bilateral orbital mucosa-associated lymphoid tissue lymphoma. Am J Ophthalmol 141:1162–1163

    Article  PubMed  Google Scholar 

  134. Shields JA (1989) Lymphoid tumors and leukemias. In: Shileds JA, Saunders WB (eds). Diagnosis and management of orbital tumors. Lippincott, Philadelphia, pp 316–340

    Google Scholar 

  135. Shipp MA, Harrington D P, Anderson JR, et al (1993) International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329(14):987–994

    Article  Google Scholar 

  136. Sjo LD (2009) Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol 87 Thesis 1:1–20

    Article  Google Scholar 

  137. Sjo LD, Ralfkiaer E, Prause JU, et al (2008) Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci 49:3283–3288

    Article  PubMed  Google Scholar 

  138. Smith JS, Munoz N, Herrero R, et al (2002) Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185:324–331

    Article  PubMed  Google Scholar 

  139. Smith M (2008) Mantle cell lymphoma: advances in biology and therapy. Curr Opin Hematol 15:415–421

    Article  PubMed  CAS  Google Scholar 

  140. Solal-Celigny P, Lepage E, Brousse N, et al (1993) Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte. N Engl J Med 329:1608–1614

    Article  PubMed  CAS  Google Scholar 

  141. Solal-Seligny P, Roy P, Colombat P, et al (2004) Follicular lymphoma international prognostic index. Blood 104:1258–1265

    Article  CAS  Google Scholar 

  142. Song EK, Kim SY, Kim TM et al (2008) Efficacy of chemotherapy as a first-line treatment in ocular adnexal extran-odal marginal zone B-cell lymphoma. Ann Oncol 19:242–246

    Article  PubMed  Google Scholar 

  143. Spagnolo DV, Ellis D W, Juneja S, et al (2004) The role of molecular studies in lymphoma diagnosis: a review. Pathology 36:19–44

    Article  PubMed  CAS  Google Scholar 

  144. Stefanovic A, Lossos I (2009) Extranodal marginal zone lymphoma of the ocular adnexa. Blood. (Prepublished online 16 April 2009)

    Google Scholar 

  145. Stein H (2001) Hodgkin lymphomas: introduction. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissue. IARC Press, Lyon, p 239

    Google Scholar 

  146. Streubel B, Simonitsch-Klupp I, Mullauer L, et al (2004) Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18:1722–1726

    Article  PubMed  CAS  Google Scholar 

  147. Sullivan TJ, Valenzuela AA (2006) Imaging features of ocular adnexal lymphoproliferative disease. Eye 20:1189–1195

    Article  PubMed  CAS  Google Scholar 

  148. Sullivan TJ, Grimes D, Bunce I (2004) Monoclonal antibody treatment of orbital lymphoma. Ophthal Plast Reconstr Surg 20:103–106

    Article  PubMed  Google Scholar 

  149. Sullivan TJ, Whitehead K, Williamson R, et al (2005) Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients. Ophthal Plast Reconstr Surg 21:177–188

    Article  PubMed  Google Scholar 

  150. Treon SP, Agus DB, Link B, et al (2001) CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia. J Immunother 24:272–279

    Article  CAS  Google Scholar 

  151. Valenzuela AA, Allen C, Grimes D, et al (2006) Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology 113:2331–2337

    Article  PubMed  Google Scholar 

  152. Westacott S, Garner A, Moseley IF, et al (1991) Orbital lymphoma vs reactive lymphoid hyperplasia: an analysis of the use of computed tomography in differential diagnosis. Br J Ophthalmol 75:722–725

    Article  PubMed  CAS  Google Scholar 

  153. White VA, Gascoyne RD, McNeil BK, et al (1996) Histopathologic findings and frequency of clonality detected by the polymerase chain reaction in ocular adn-exal lymphoproliferative lesions. Mod Pathol 9:1052–1061

    PubMed  CAS  Google Scholar 

  154. White WL, Ferry JA, Harris NL, et al (1995) Ocular adn-exal lymphoma. A clinicopathologic study with identifi-cation of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 102:1994–2006

    CAS  Google Scholar 

  155. Whiteside TL, Rowlands DT Jr (1977) T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Am J Pathol 88:754–792

    CAS  Google Scholar 

  156. Woog JJ, Kim YK, Yeatts RP, et al (2006) Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 113:140–145

    Article  PubMed  Google Scholar 

  157. Wündisch T, Tiede C, Morgner A, et al (2005) Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 23:8018–8024

    Article  PubMed  Google Scholar 

  158. Yeo JH, Jakobiec FA, Abbott GF, et al (1982) Combined clinical and computed tomographic diagnosis of orbital lymphoid tumors. Am J Ophthalmol 94:235–245

    PubMed  CAS  Google Scholar 

  159. Zhang G, Winter J, Variakojis D (2007) Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma. Leuk Lymphoma 48:577–583

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Queensland, Eyelid, Lacrimal and Orbital Clinic, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, Brisbane, 4029, Australia

    Timothy J Sullivan

Authors
  1. Timothy J Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, University of Rostock, Doberaner Straße 140, 18055, Rostock, Germany

    Rudolf F. Guthoff (Professor of Ophthalmology) (Professor of Ophthalmology)

  2. Children's Hospital of Philadelphia, R. D. Wood Ambulatory Care Building Division of Ophthalmology, 34th Street Civic Center Blvd., Philadelphia, PA, 19104, USA

    James A. Katowitz (Professor of Ophthalmology) (Professor of Ophthalmology)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sullivan, T.J. (2010). Ocular Adnexal Lymphoproliferative Disease. In: Guthoff, R.F., Katowitz, J.A. (eds) Oculoplastics and Orbit. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85542-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-85542-2_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-85541-5

  • Online ISBN: 978-3-540-85542-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation